Wijngaard Peter 4
4 · Hepion Pharmaceuticals, Inc. · Filed Sep 20, 2023
Insider Transaction Report
Form 4
Wijngaard Peter
Director
Transactions
- Purchase
Common Stock
2023-09-15$5.37/sh+861$4,624→ 3,501 total - Purchase
Common Stock
2023-09-15$5.45/sh+139$758→ 2,640 total - Purchase
Common Stock
2023-09-15$5.82/sh+1,000$5,820→ 2,501 total - Purchase
Common Stock
2023-09-19$5.64/sh+1,000$5,640→ 4,501 total